Loading market dashboard
Fennec Pharmaceuticals Inc.
FRX.TOHealthcareTSXUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Fennec Pharmaceuticals Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $210.80M | $184.98M - $242.94M | -$27.21M | $2.958 | 6 |
| Dec 2029 | $192.43M | $168.85M - $221.76M | -$24.84M | $2.733 | 3 |
| Dec 2028 | $139.79M | $122.67M - $161.10M | -$18.05M | $1.682 | 4 |
| Dec 2027 | $102.33M | $83.92M - $125.49M | -$13.21M | $1.009 | 7 |
| Dec 2026 | $68.32M | $65.79M - $71.22M | -$8.82M | $0.262 | 7 |
| Dec 2025 | $45.60M | $44.72M - $46.67M | -$5.89M | -$0.13 | 6 |
| Dec 2024 | $43.03M | $36.23M - $69.24M | -$5.55M | -$0.073 | 5 |
| Dec 2023 | $20.66M | $17.82M - $22.61M | -$6.18M | -$0.522 | 2 |
| Dec 2022 | $891.3K | $771.1K - $969.8K | -$266.4K | -$0.911 | 1 |
| Dec 2021 | $50.15M | $43.39M - $54.57M | -$14.99M | $0.254 | 2 |